We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
-2.78%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$1.27T
AUM Growth
-$18.6B
Cap. Flow
+$47.9B
Cap. Flow %
3.77%
Top 10 Hldgs %
28.89%
Holding
4,591
New
121
Increased
3,781
Reduced
412
Closed
115

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.99B
2
AAPL icon
Apple
AAPL
+$2.23B
3
NVDA icon
NVIDIA
NVDA
+$1.92B
4
AMZN icon
Amazon
AMZN
+$1.75B
5
META icon
Meta Platforms (Facebook)
META
+$1.1B

Sector Composition

Rank Sector Weight
1 Technology 29.36%
2 Financials 14.54%
3 Healthcare 11.04%
4 Consumer Discretionary 10.44%
5 Communication Services 8.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OLB icon
4401
OLB
OLB
$4.28M
$14.9K ﹤0.01%
+12,522
New +$17.9K
MDXH icon
4402
MDxHealth
MDXH
$21.5M
$14.8K ﹤0.01%
10,394
FRMM
4403
Forum Markets
FRMM
$68.2M
$14.6K ﹤0.01%
+1,493
New +$19.7K
NRSN icon
4404
NeuroSense Therapeutics
NRSN
$16.8M
$14.6K ﹤0.01%
15,870
CDT icon
4405
CDT Equity Inc
CDT
$1.85M
$14.6K ﹤0.01%
+1
New +$90.2K
PTHS
4406
Pelthos Therapeutics
PTHS
$99.6M
$14.3K ﹤0.01%
+1,007
New +$17.2K
YIBO icon
4407
Planet Image International
YIBO
$73.5M
$14K ﹤0.01%
+12,104
New +$27.8K
HSDT icon
4408
Solana Company
HSDT
$96.3M
$14K ﹤0.01%
47
+18
+62% +$7.63K
ZVSA
4409
DELISTED
ZyVersa Therapeutics
ZVSA
$13.6K ﹤0.01%
+21,706
New +$24.5K
CLLS
4410
Cellectis
CLLS
$277M
$13.4K ﹤0.01%
10,776
SHPH icon
4411
Shuttle Pharmaceuticals
SHPH
$2.22M
$13.2K ﹤0.01%
136
+93
+216% +$15.1K
PRHI
4412
Presurance Holdings
PRHI
$21.2M
$13.2K ﹤0.01%
3,683
-88
-2% -$574
TRNR icon
4413
Interactive Strength
TRNR
$1.55M
$13.2K ﹤0.01%
+15
New +$19.7K
ELPW
4414
Elong Power Holding Ltd
ELPW
$2.56M
$13.1K ﹤0.01%
14
PMEC icon
4415
Primech Holdings
PMEC
$16.1M
$12.7K ﹤0.01%
16,381
PCSA icon
4416
Processa Pharmaceuticals
PCSA
$5.95M
$12.7K ﹤0.01%
1,377
+498
+57% +$7.5K
BANL icon
4417
CBL International Ltd
BANL
$9.59M
$12.4K ﹤0.01%
1,000
AWH
4418
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$12.4K ﹤0.01%
131,968
+33,860
+35% +$10.6K
CERO
4419
DELISTED
CERo Therapeutics
CERO
$12.3K ﹤0.01%
+846
New +$33.4K
MTC icon
4420
MMTec
MTC
$404M
$12.3K ﹤0.01%
14,496
BTOC
4421
Armlogi Holding Corp
BTOC
$11.4M
$12.3K ﹤0.01%
+12,265
New +$34.7K
APVO icon
4422
Aptevo Therapeutics
APVO
$5.12M
$12.2K ﹤0.01%
+29
New +$36.7K
HCTI icon
4423
Healthcare Triangle
HCTI
$2.23M
$11.8K ﹤0.01%
3
+1
+50% +$9.24K
ZONE
4424
CleanCore Solutions
ZONE
$80.3M
$11.7K ﹤0.01%
+12,308
New +$14.3K
HYPD
4425
Hyperion DeFi Inc
HYPD
$40M
$11.5K ﹤0.01%
10,412
+3,195
+44% +$10.2K

Similar funds

Geode Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Geode Capital Management held 4,591 positions worth $1.27T, down 1.4% from $1.29T the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Geode Capital Management deployed $47.9B of net new capital in Q1 2025, opening 121 new positions and adding to 3,781 existing holdings. Its largest new stake was Sandisk: 1,936,245 shares worth $92.2M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Merck, an estimated $142M trimmed.

  • Geode Capital Management's largest Q1 2025 buy was Sandisk: 1,936,245 shares worth $92.2M.
  • Geode Capital Management added most to Microsoft in Q1 2025, an estimated $2.99B increase.
  • Geode Capital Management's biggest Q1 2025 reduction was Merck, cutting an estimated $142M.
  • Geode Capital Management fully exited Altair Engineering Inc in Q1 2025, selling an estimated $152M.
  • Geode Capital Management's ten largest holdings make up 29% of its $1.27T portfolio in Q1 2025.
  • Geode Capital Management opened 121 new positions and closed 115 in Q1 2025.
  • Geode Capital Management's portfolio value fell 1.4% quarter-over-quarter to $1.27T.

Based on Geode Capital Management's 13F filing for Q1 2025, filed 13 May 2025.